Quick Answer
The only peptide medicine approved for a sleep condition is tirzepatide, for sleep apnea in adults with obesity. DSIP is the only peptide tested directly on sleep in people, and its effect was weak. Epitalon, Selank, CJC-1295 with ipamorelin, sermorelin and others were tested on hormones, melatonin or anxiety rather than sleep, and none is FDA-approved for insomnia.
Most peptides for sleep have never been tested on sleep. They were tested on something nearby, such as a hormone level or the body clock, and the sleep benefit was assumed afterwards. This guide covers the peptides people ask about most and shows what the research actually measured for each one.
Before looking at any peptide, it helps to know why you sleep badly. One cause that is easy to miss is sleep apnea, a breathing problem during sleep, and no peptide in this guide treats it.
Key Takeaways
- No peptide is FDA-approved for insomnia or for improving sleep quality.
- DSIP is the only peptide here that was tested directly on sleep in people, and its effect was weak.
- Most popular sleep peptides were tested on hormones, not on sleep.
- One peptide medicine, tirzepatide, is approved for a sleep condition, but only for sleep apnea in adults with obesity.
- Rule out sleep apnea and other causes before considering any peptide.
How We Built This List
Each peptide is ranked on four things: whether sleep was measured in people, how strong that study was, what is known about its safety, and its FDA status. We used published studies and FDA records as of October 2026, and our pulmonary and critical care physician reviewed every entry.
Patients often ask about peptides for sleep after reading about them online, so we wrote the guide we wish they had found first. A higher rank means stronger evidence about sleep. It is not a recommendation to use that peptide.
Peptides for Sleep at a Glance
Only one peptide in this list was tested directly on sleep in people: DSIP. Epitalon research measured melatonin, not sleep. The rest were studied for hormones, anxiety, focus or tissue repair.
Best Peptides for Sleep, Ranked by Evidence
The list starts with the peptide that has the most direct sleep research and ends with those that have none. For each one, we show whether sleep was tested in people, its FDA status, what the research shows and its limitations.
1. DSIP: The Only Peptide Tested Directly on Sleep
- Sleep tested in people: Yes, with a weak effect
- FDA status: Not approved. In July 2026, an FDA advisory committee voted against adding it to the list of ingredients pharmacies may use
What it is: DSIP (delta sleep-inducing peptide) is a nine-amino acid peptide. Researchers found it in 1977 while studying deep sleep in rabbits.
What the research shows: In a 1992 study of 16 people with long-term insomnia, those given DSIP spent slightly more of the night asleep and fell asleep faster than those given a placebo (a dummy treatment). The researchers called the effects weak and said part of the difference may have come from changes in the placebo group. Patients did not rate their sleep as any better, and the authors concluded DSIP is unlikely to help much with chronic insomnia.
Limitations: The study gave DSIP into a vein, while it is now usually promoted as an injection under the skin. Its receptor, the part of the body it acts on, has never been found.
2. Epitalon: Studied for the Body Clock
- Sleep tested in people: Partly. Researchers measured melatonin, not sleep
- FDA status: Not approved. In July 2026, an FDA advisory committee recommended adding it to the compounding list after reviewing it for insomnia. The vote is not binding, FDA's own scientists recommended against it, and FDA has not acted as of October 2026
What it is: A four-amino acid peptide modeled on peptides from the pineal gland, the small gland in the brain that makes melatonin. Melatonin is the hormone that signals to your body that it is night.
What the research shows: One research group in St. Petersburg reported that Epitalon brought back the night-time rise in melatonin in older monkeys and elderly people. Melatonin naturally falls with age.
Limitations: Almost all of the research comes from one lab and has not been repeated by independent researchers. Sleep itself was not measured. Epitalon also acts on telomerase, an enzyme linked to cell aging, which is a reason for caution in anyone with a history of cancer.
3. Selank: Studied for Anxiety
- Sleep tested in people: No. Only anxiety was measured
- FDA status: Not approved in the US. It is a prescription medicine in Russia
What it is: A seven-amino acid peptide based on tuftsin, a short immune signal the body makes on its own.
What the research shows: Small Russian trials compared Selank with phenazepam, a strong benzodiazepine sedative, in people with anxiety disorders. They reported similar anxiety relief without sedation. Lab and animal studies suggest Selank influences GABA, the brain's main calming signal.
Limitations: No trial has measured sleep. The trials were small and run in one country. If you fall asleep easily but wake unrested, anxiety research does not address your problem.
4. CJC-1295 and Ipamorelin: The Most Popular, but Not Tested on Sleep
- Sleep tested in people: No. Only hormone levels were measured
- FDA status: Not approved. FDA previously flagged both as compounding ingredients that may carry significant safety risks, and neither is on the list of ingredients pharmacies may use. Both are banned in competitive sport
What it is: CJC-1295 copies GHRH, the brain's signal to release growth hormone. Ipamorelin acts on the ghrelin receptor, a second route to growth hormone release. They are often promoted together.
What the research shows: In healthy adults, a long-acting version of CJC-1295 raised growth hormone 2 to 10 times for six days or more. In animal research, ipamorelin raised growth hormone without raising cortisol, the main stress hormone.
Limitations: No study has measured what this pair does to sleep. The human trial used the long-acting version of CJC-1295, not the short-acting form usually promoted for sleep. As explained below, raising growth hormone does not reliably deepen sleep.
5. Sermorelin: A Copy of the Brain's Growth Hormone Signal
- Sleep tested in people: No
- FDA status: Once approved for children with growth hormone deficiency. The maker discontinued it in 2008, and FDA recorded that this was not for safety or effectiveness reasons. It was never approved for sleep
What it is: A copy of the first 29 amino acids of GHRH, the signal the brain uses to release growth hormone.
What the research shows: Sermorelin raises growth hormone, and its approved use was growth in children. No trial has tested sermorelin itself on sleep.
Limitations: Sleep claims rest on the link between growth hormone and deep sleep, not on sleep studies.
6. Semax: Studied for Stress and Focus
- Sleep tested in people: No. The key research was in rats
- FDA status: Not approved. In July 2026, an FDA advisory committee recommended it for neurologic uses, not sleep. The vote is not binding
What it is: A seven-amino acid peptide built on a four-amino acid piece of ACTH, the hormone that tells your body to make cortisol. Three amino acids were added so it lasts longer. The piece it uses does not trigger cortisol release.
What the research shows: In rats, Semax raised BDNF, a protein that supports brain cells.
Limitations: There is no sleep data. Semax is generally described as activating, which is the opposite of what most people want before bed.
7. Pinealon: Sleep Claims Without Sleep Research
- Sleep tested in people: No
- FDA status: Not approved. In the US, it is sold only as a research chemical
What it is: A three-amino acid peptide from the same St. Petersburg research program as Epitalon.
What the research shows: No published study has measured its effect on sleep. The sleep claims found online come from personal accounts.
Limitations: Epitalon's melatonin research is often quoted in support of Pinealon. They are different compounds, and only Epitalon has that data.
8. BPC-157, TB-500 and Thymosin Alpha-1: Recovery Peptides
- Sleep tested in people: No
- FDA status: None is FDA-approved. In July 2026, an FDA advisory committee recommended BPC-157 and TB-500 for other uses, such as ulcerative colitis and wound healing. The vote is not binding
What they are: BPC-157 is based on a protein found in stomach juice. TB-500 is a short fragment of a repair protein called thymosin beta-4. Thymosin Alpha-1 is an immune signal made by the thymus gland.
What the research shows: Research focuses on healing and inflammation, and is mostly in animals. A 2025 review of BPC-157 found the evidence was almost entirely from animal studies.
Limitations: No controlled study has measured sleep. People taking them for injuries sometimes say they sleep better, likely because pain disrupts sleep. That is not evidence that these peptides affect sleep.
A note on our role: Unify Care does not prescribe, sell, supply or source any of the peptides in this guide. Our physicians provide independent consultation, assessment and monitoring. The peptide prescription is possible only after the consultation and assessment. Unify Care only prescribes FDA-approved peptide products.
Does More Growth Hormone Mean Better Sleep?
Not reliably. Deep sleep triggers growth hormone, but raising growth hormone does not reliably deepen sleep. When researchers tested compounds that raise growth hormone in sleep labs, the results went in different directions.
Your body releases its main pulse of growth hormone soon after you fall into deep sleep, and both decline with age. That is where the popular claim comes from.
- Ghrelin, a natural hunger hormone that also releases growth hormone, increased deep sleep in men.
- Hexarelin, a similar compound, reduced deep sleep.
- GHRH, the brain's own growth hormone signal, deepened sleep in young men but worsened it in young women.
If more growth hormone were what improved sleep, these results would agree. They do not. Treat any sleep claim based on growth hormone or IGF-1 levels as a hormone result, not a sleep result. IGF-1 is the blood marker doctors use to track growth hormone.
The Only Peptide Medicine Approved for a Sleep Condition
Tirzepatide (Zepbound) is the only peptide medicine FDA-approved for a sleep condition. FDA approved it on December 20, 2024, for moderate to severe obstructive sleep apnea in adults with obesity, used with a reduced-calorie diet and more physical activity.
The approval was based on two year-long trials in 469 adults without type 2 diabetes. FDA states that the breathing improvement is likely related to weight loss. Semaglutide also causes weight loss, but it is not approved for sleep apnea. Read more in our comparison of tirzepatide vs semaglutide.
Which Peptide Matches Your Sleep Problem?
Different sleep problems have different causes, and the peptide research covers only some of them. Start with the cause.
The last row is the one to take most seriously. Loud snoring with daytime sleepiness is the classic pattern of sleep apnea, and no peptide in this guide treats it.
What to Rule Out Before Trying Any Peptide
Most long-running sleep problems have a cause, and the cause is often treatable. Check these first.
- Obstructive sleep apnea. Signs include snoring, pauses in breathing that others notice, waking with a dry mouth or headache, and daytime sleepiness. An overnight sleep study confirms it.
- Thyroid problems. An overactive thyroid can cause insomnia, and an underactive one can make sleep feel unrefreshing. A blood test checks this.
- Low iron. It is linked to restless legs, which can break up sleep without you remembering waking.
- Alcohol. It can help you fall asleep but disrupts the second half of the night.
- Medications. Blood pressure drugs, steroids, stimulants, decongestants and some antidepressants can all affect sleep.
- Depression and anxiety. Waking very early and not getting back to sleep is a recognized pattern in depression.
- Blood sugar changes. Waking in the middle of the night may be linked to drops in blood sugar in some people.
Do Peptides Work Better Than Melatonin or Sleep Medication?
No study has compared sleep peptides with melatonin, sleep medication or CBT-I. Melatonin and several FDA-approved sleep medications have been tested on sleep in controlled trials, which none of the peptides in this guide have.
CBT-I, cognitive behavioral therapy for insomnia, is a short course of structured talk therapy, and medical guidelines recommend it as the first treatment for chronic insomnia. If insomnia is your main problem, these are the options to discuss with a physician first.
Sleep Options Compared
Safety and What to Monitor
None of these peptides has long-term safety data in people for sleep use. These are the known and possible risks.
Known and Possible Risks
- Blood sugar and thyroid. Raising growth hormone can raise blood sugar and change thyroid hormone levels.
- Cancer risk. Raising growth hormone carries a theoretical risk for anyone with an undiagnosed cancer. Epitalon's effect on telomerase is a reason for caution in anyone with a cancer history.
- Immune reactions and impurities. FDA has flagged several of these peptides, including ipamorelin and CJC-1295, as compounding ingredients that may carry significant safety risks for these reasons. BPC-157 was moved off that list in April 2026, but that did not make it legal to compound.
- Products bought online. Peptides sold as "research use only" have no checks on purity, strength, sterility, or even what is in the vial.
Normal lab results do not prove a product is safe or that it contains what the label says. They show only what was measured at that time.
Peptide Therapy at Unify Care: Consultation and Monitoring
If you are thinking about using a peptide for sleep, or you already use one, we can help you weigh the evidence and watch for problems. That is what our peptide therapy service is built on.
- Considering a sleep peptide? We will review your goals, health history and medications, explain what the research on that peptide does and does not show, and talk through the risks that matter for you.
- Already using one? We monitor you with baseline and follow-up lab tests, regular check-ins and clear signs to stop, so problems such as rising blood sugar can be caught early.
- Symptoms that point elsewhere? If your symptoms, such as loud snoring or daytime sleepiness, suggest a problem no peptide treats, we will tell you.
We do not prescribe, sell, supply or source peptides that are not approved by FDA. We offer in-home and telehealth consultations across Orange County, Los Angeles, Riverside, San Bernardino, Palm Springs and San Diego.
Frequently Asked Questions
What is the best peptide for sleep?
No peptide is FDA-approved for sleep. DSIP has the most direct evidence, as the only peptide tested on sleep in people, but its effect was weak. The others were tested on hormones, melatonin or anxiety, not on sleep.
Can I get sleep peptides legally in the US?
None of them is FDA-approved for sleep. As of October 2026, most are not on the list of ingredients US pharmacies may use for compounding. An FDA advisory committee recommended adding Epitalon, Semax, BPC-157 and TB-500 in July 2026, but the FDA has not acted on that vote. Products sold online as "research use only" are not intended for people.
Why does this guide not list doses?
None of these peptides is approved for sleep, and no safe dose has been established for sleep use. A safe approach also depends on your health, medications and medical history.
How fast do sleep peptides work?
There is no reliable research on how long these peptides take to affect sleep, or whether they affect it at all. Claims of results within days or weeks come from personal accounts, not studies.
Can I combine sleep peptides?
No study has tested any combination of these peptides for sleep. Combining compounds also makes it harder to tell what is causing a side effect.
Is MK-677 a sleep peptide?
No. MK-677 is not a peptide. It is an oral compound that copies ghrelin, the hunger hormone. A small 1997 sleep lab study found more deep sleep in young adults and more REM sleep in older adults. A larger year-long trial in older adults found it raised fasting blood sugar and lowered insulin sensitivity. It has never been approved for any use and is sold only as a research chemical.
Is there any peptide approved for sleep apnea?
Yes. Tirzepatide (Zepbound) was FDA-approved in December 2024 for moderate to severe obstructive sleep apnea in adults with obesity. FDA states the benefit is likely related to weight loss.
Book a peptide therapy consultation or call (949) 979-6956.
Medical disclaimer: This article is for educational purposes only and is not medical advice. None of the peptides discussed is FDA-approved for sleep. Talk to a qualified physician before starting, stopping or changing any treatment.
Sources
- FDA Approves First Medication for Obstructive Sleep Apnea. US Food and Drug Administration. December 20, 2024.
- Bes F, et al. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. 1992;26(4):193–197. PubMed
- Khavinson VK, et al. Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people. Advances in Gerontology. 2007;20(1):74–85.
- Zozulya AA, et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17–22.
- Teichman SL, et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799–805.
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561.
- Dolotov OV, et al. Semax binds specifically and increases BDNF in the rat basal forebrain. J Neurochem. 2006.
- Vasireddi N, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS Journal. 2025.
- Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Invest. 1968;47(9):2079–2090.
- Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA. 2000;284(7):861–868.
- Weikel JC, et al. Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab. 2003.
- Frieboes RM, et al. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Psychoneuroendocrinology. 2004.
- Mathias S, et al. Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women. 2007.
- Copinschi G, et al. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology. 1997;66(4):278–286.
- Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008;149(9):601–611.
- Qaseem A, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133.
- July 23–24, 2026 Meeting of the Pharmacy Compounding Advisory Committee. US Food and Drug Administration.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. US Food and Drug Administration.
